Cited by 224Neurogenesis and neuroplasticity mechanismsPluripotent Stem Cells ResearchMesenchymal stem cell research

Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview

Open access
Sivandzade, Farzane, Cucullo, Luca·2021·International Journal of Molecular Sciences

Abstract

Neurodegenerative diseases resulting from the progressive loss of structure and/or function of neurons contribute to different paralysis degrees and loss of cognition and sensation. The lack of successful curative therapies for neurodegenerative disorders leads to a considerable burden on society and a high economic impact. Over the past 20 years, regenerative cell therapy, also known as stem cell therapy, has provided an excellent opportunity to investigate potentially powerful innovative strategies for treating neurodegenerative diseases. This is due to stem cells’ capability to repair injured neuronal tissue by replacing the damaged or lost cells with differentiated cells, providing a conducive environment that is in favor of regeneration, or protecting the existing healthy neurons and glial cells from further damage. Thus, in this review, the various types of stem cells, the current knowledge of stem-cell-based therapies in neurodegenerative diseases, and the recent advances in this field are summarized. Indeed, a better understanding and further studies of stem cell technologies cause progress into realistic and efficacious treatments of neurodegenerative disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms22042153

Cites

153 of 153 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Many researchers have invested considerable effort into exploring regenerative cell therapy (stem cell therapy) to restore neuron loss during neurodegeneration and CNS injury.

    “Many researchers have invested considerable effort into exploring regenerative cell therapy, also known as stem cell therapy, to restore neuron loss during neurodegeneration and CNS injury [107].”

    From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [107]

    Section 3 states that investigators have made extensive efforts to produce neurons and glial cells from stem cells to treat neurodegenerative diseases, including replacing neural networks lost to disease. The Introduction describes repairing damaged tissue, but the passages found do not establish the same research effort specifically for CNS injury as a distinct condition. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sivandzade, F., & Cucullo, L.
Affiliations
Oakland University (US)
Corresponding author
Cucullo, Luca
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2021-02-22
Volume
22
Issue
4
Pages
2153
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3129268793
Cited by
224
References
153
Citations by year
2026: 30 · 2025: 55 · 2024: 64 · 2023: 43 · 2022: 23 · 2021: 9
FWCI
5.16
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institute on Drug Abuse (2R01-DA029121, 1R01-DA049737)
  • National Institute of Neurological Disorders and Stroke (1R01NS117906)
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
Keywords
stem cell therapy, neurodegenerative diseases, regenerative cell therapy, stem cell types, neuroprotection, glial cells, cell differentiation, paralysis, cognitive impairment
MeSH terms
Animals, Cell Differentiation, Humans, Neurons, Regeneration, Stem Cells, Neurodegenerative Diseases, Stem Cell Transplantation, Regenerative Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review